SkyePharma PLC (SKP) Company Profile - CorporateInformation.com


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

SkyePharma PLC Company Snapshot

Business Description:

SkyePharma PLC operates in the Pharmaceutical preparations sector. SkyePharma PLC is a drug delivery company developing oral and inhalation products. The principal activities of the Company included the research and development, manufacture and sale of prescription pharmaceutical products. The Company is engaged in the development and manufacture of pharmaceutical products based on information used internally by management to assess the performance of, and allocate resources to the business. The Company's subsidiaries include SkyePharma Production SAS, SkyePharma (Jersey) Limited, Jago Holding AG, Jagotec AG, SkyePharma AG, SkyePharma Holding AG, SkyePharma Holding Inc. and SkyePharma US Inc. In our complete report available for purchase the company is compared to: Alliance Pharma Plc, Vectura Group PLC and Allergy Therapeutics PLC.

SkyePharma PLC

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 34.50p
(Figures in Pounds Sterling)

1 Week	0.7%	13 Weeks	-2.8%

4 Weeks	-34.3%	52 Weeks	-2.1%

SkyePharma PLC Key Data:

Ticker:	SKP	Country:	UNITED KINGDOM

Exchanges:	LON	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Diversified Drugs, Cosmetics, & Health Care

2010 Sales	58,100,000 (Year Ending Jan 2011).	Employees:	211

Currency:	Pounds Sterling	Market Cap:	8,260,391

Fiscal Yr Ends:	December	Shares Outstanding:	23,943,162

Share Type:	Ordinary	Closely Held Shares:	7,788,503

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.